Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Puma Biotechnology (PBYI) Non-cash Items (2017 - 2025)

Puma Biotechnology (PBYI) has disclosed Non-cash Items for 9 consecutive years, with $2.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non-cash Items rose 798.26% year-over-year to $2.8 million, compared with a TTM value of $2.8 million through Dec 2025, up 798.26%, and an annual FY2025 reading of $2.8 million, up 798.26% over the prior year.
  • Non-cash Items was $2.8 million for Q4 2025 at Puma Biotechnology, up from $2.8 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $4.0 million in Q1 2024 and bottomed at $19000.0 in Q3 2022.
  • Average Non-cash Items over 5 years is $1.5 million, with a median of $1.0 million recorded in 2022.
  • The sharpest move saw Non-cash Items crashed 98.24% in 2022, then surged 2915.22% in 2025.
  • Year by year, Non-cash Items stood at $1.1 million in 2021, then fell by 3.06% to $1.0 million in 2022, then rose by 5.64% to $1.1 million in 2023, then plummeted by 71.67% to $313000.0 in 2024, then soared by 798.26% to $2.8 million in 2025.
  • Business Quant data shows Non-cash Items for PBYI at $2.8 million in Q4 2025, $2.8 million in Q3 2025, and $726000.0 in Q2 2025.